InvestorsHub Logo
Followers 38
Posts 1444
Boards Moderated 0
Alias Born 03/24/2009

Re: None

Friday, 09/15/2023 8:39:34 AM

Friday, September 15, 2023 8:39:34 AM

Post# of 2833
HC Wainwright& Co. analyst Joseph Pantginis maintains BioLine Rx (NASDAQ:BLRX) with a Buy and raises the price target from $19 to $21.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BLRX News